Related Experiment Video
Updated: Apr 15, 2026
11:19
Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
18.9K
Paediatric doses in St Petersburg hospitals
Ilya Shatskiy1, Vladislav Golikov2
1St-Petersburg Research Institute of Radiation Hygiene, Mira st. 8, St Petersburg, Russian Federation i.shatskiy@niirg.ru mcirosh@gmail.com.
Radiation Protection Dosimetry
|April 8, 2015
Summary
Paediatric patients
Area of Science:
- Medical Physics
- Radiological Protection
- Pediatric Imaging
Background:
- Diagnostic X-ray procedures are essential in pediatric care.
- Assessing radiation exposure in children is crucial for minimizing long-term health risks.
- Standardized radiation dose data for pediatric radiography is lacking in many regions.
Purpose of the Study:
- To investigate and quantify radiation exposure levels in pediatric patients undergoing X-ray examinations.
- To establish baseline data for effective doses and entrance surface air kerma in St Petersburg hospitals.
- To compare current practices with international standards for pediatric radiography.
Main Methods:
- Collected data on radiography examinations performed on pediatric patients.
- Estimated mean patient effective doses for various X-ray procedures.
- Calculated entrance surface air kerma for each X-ray unit utilized.
Main Results:
- Quantified radiation doses for pediatric X-ray examinations in St Petersburg.
- Identified variations in patient effective doses and entrance surface air kerma across different X-ray units.
- Provided comparative data against international benchmarks for pediatric radiation exposure.
Conclusions:
- The study provides essential data on pediatric radiation exposure in St Petersburg.
- Findings will inform the optimization of pediatric X-ray examinations in Russia.
- This research supports the implementation of evidence-based radiological protection strategies for children.
Related Concept Videos
01:29Drug Dosing: Infants and Children
886
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
886
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
391
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
505
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
505
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
838
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
838
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
360
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
360
01:21Factors Affecting Drug Response: Overview
3.3K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.3K